Completed OBSERVATIONAL NCT04413149

Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.

Observational Study of Clinical Features and Outcome of Interstitial Lung Disease With Anti-neutrophil Cytoplasmic Antibody in Chinese Patients.

Sponsor: Peking Union Medical College Hospital

Conditions Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Interstitial Lung Disease

Updated 7 times since 2020 Last updated: May 10, 2024 Started: Apr 1, 2014 Primary completion: Apr 1, 2019 Completion: Apr 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04413149, this observational or N/A phase trial focuses on Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis and Interstitial Lung Disease and remains completed. Sponsored by Peking Union Medical College Hospital, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2024 — Jul 2024 [monthly]

Completed
Dec 2021 — Jun 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed
Jul 2020 — Nov 2020 [monthly]

Completed

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China